AUF DER MAUR, ADRIAN,LICHTLEN, PETER,BARBERIS, ALCIDE
申请号：
CA2650822
公开号：
CA2650822C
申请日:
2007.04.27
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention concerns an antibody specific for human ALK (Anaplastic Lymphoma Kinase), in particular a scFv, a nucleic acid sequence encoding it, its production and its use as a pharmaceutical or for diagnostic purposes. Said antibody is suitable for the local treatment of tumors, in particular glioblastoma.
